UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 94

Sortiert nach

Passive immunization reduces behavioral and neuropathological deficits in an alpha-synuclein transgenic model of Lewy body disease

PloS one, 2011-04, Vol.6 (4), p.e19338-e19338

2011

Volltextzugriff (PDF)

Partial Reduction of BACE1 Has Dramatic Effects on Alzheimer Plaque and Synaptic Pathology in APP Transgenic Mice

The Journal of biological chemistry, 2007-09, Vol.282 (36), p.26326-26334

2007

Volltextzugriff (PDF)

Epitope and Isotype Specificities of Antibodies to β-Amyloid Peptide for Protection against Alzheimer's Disease-like Neuropathology

Proceedings of the National Academy of Sciences - PNAS, 2003-02, Vol.100 (4), p.2023-2028

2003

Volltextzugriff (PDF)

Alterations in synaptic transmission and long-term potentiation in hippocampal slices from young and aged PDAPP mice

Brain research, 1999-09, Vol.840 (1), p.23-35

1999

Volltextzugriff (PDF)

Dentate Gyrus Volume Is Reduced before Onset of Plaque Formation in PDAPP Mice: A Magnetic Resonance Microscopy and Stereologic Analysis

Proceedings of the National Academy of Sciences - PNAS, 2003-02, Vol.100 (3), p.1381-1386

2003

Volltextzugriff (PDF)

Amyloid Deposition in the Hippocampus and Entorhinal Cortex: Quantitative Analysis of a Transgenic Mouse Model

Proceedings of the National Academy of Sciences - PNAS, 2003-04, Vol.100 (8), p.4837-4842

2003

Volltextzugriff (PDF)

Cholinergic neuropathology in a mouse model of Alzheimer's disease

Journal of comparative neurology (1911), 2003-08, Vol.462 (4), p.371-381

2003

Volltextzugriff (PDF)

Selective Vulnerability of Dentate Granule Cells Prior to Amyloid Deposition in PDAPP Mice: Digital Morphometric Analyses

Proceedings of the National Academy of Sciences - PNAS, 2004-05, Vol.101 (18), p.7141-7146

2004

Volltextzugriff (PDF)

The PDAPP mouse model of Alzheimer's disease: Locus coeruleus neuronal shrinkage

Journal of comparative neurology (1911), 2005-11, Vol.492 (4), p.469-476

2005

Volltextzugriff (PDF)

Reducing C-terminal-truncated alpha-synuclein by immunotherapy attenuates neurodegeneration and propagation in Parkinson's disease-like models

The Journal of neuroscience, 2014-07, Vol.34 (28), p.9441-9454

2014

Volltextzugriff (PDF)

Axonopathy in an α -Synuclein Transgenic Model of Lewy Body Disease Is Associated with Extensive Accumulation of C-Terminal–Truncated α -Synuclein

The American journal of pathology, 2013-03, Vol.182 (3), p.940-953

2013

Volltextzugriff (PDF)

Effects of α-Synuclein Immunization in a Mouse Model of Parkinson’s Disease

Neuron (Cambridge, Mass.), 2005-06, Vol.46 (6), p.857-868

2005

Volltextzugriff (PDF)

Anti-α-synuclein immunotherapy reduces α-synuclein propagation in the axon and degeneration in a combined viral vector and transgenic model of synucleinopathy

Acta neuropathologica communications, 2017-01, Vol.5 (1), p.7-7, Article 7

2017

Volltextzugriff (PDF)

Aβ Species Removal After Aβ42 Immunization

Journal of neuropathology and experimental neurology, 2006-11, Vol.65 (11), p.1040-1048

2006

Volltextzugriff (PDF)

Decreased adult hippocampal neurogenesis in the PDAPP mouse model of Alzheimer's disease

Journal of comparative neurology (1911), 2006-03, Vol.495 (1), p.70-83

2006

Volltextzugriff (PDF)

S5-03-06: The role of preclinical models in the discovery and development of anti-abeta immunotherapeutics for Alzheimer's disease

Alzheimer's & dementia, 2008-07, Vol.4 (4), p.T203-T204

Games, Dora

2008

Volltextzugriff (PDF)

Immunotherapy reduces vascular amyloid-beta in PDAPP mice

The Journal of neuroscience, 2008-07, Vol.28 (27), p.6787-6793

2008

Volltextzugriff (PDF)

Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

Nature medicine, 2000-08, Vol.6 (8), p.916-919

2000

Volltextzugriff (PDF)

Neutralization of soluble, synaptotoxic amyloid β species by antibodies is epitope specific

The Journal of neuroscience, 2012-02, Vol.32 (8), p.2696-2702

2012

Volltextzugriff (PDF)

Mice as models: transgenic approaches and Alzheimer's disease

Journal of Alzheimer's disease, 2006-01, Vol.9 (3 Suppl), p.133

2006

Volltextzugriff (PDF)

Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse

Nature (London), 1999-07, Vol.400 (6740), p.173-177

1999

Volltextzugriff (PDF)

Apolipoprotein D mRNA expression is elevated in PDAPP transgenic mice

Journal of neurochemistry, 2001-12, Vol.79 (5), p.1059-1064

2001

Volltextzugriff (PDF)

Vascular alterations in PDAPP mice after anti-Aβ immunotherapy: Implications for amyloid-related imaging abnormalities

Alzheimer's & dementia, 2013-10, Vol.9 (5), p.S105-S115

2013

Volltextzugriff (PDF)

Beta-amyloid immunotherapy prevents synaptic degeneration in a mouse model of Alzheimer's disease

The Journal of neuroscience, 2005-10, Vol.25 (40), p.9096-9101

2005

Volltextzugriff (PDF)

Non-Fc-Mediated Mechanisms Are Involved in Clearance of Amyloid-beta In Vivo by Immunotherapy

The Journal of neuroscience, 2002-09, Vol.22 (18), p.7873-7878

2002

Volltextzugriff (PDF)

1 – 25 von 94

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(91)
Mit Volltextzugriff
(91)

Publikationsform

Sprache

Englisch
(94)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

Science & Technology
(47)
Animals
(46)
Mice
(43)
Life Sciences & Biomedicine
(39)
Mice, Transgenic
(35)
Neurosciences
(31)
Humans
(30)
Neurosciences & Neurology
(29)
Alzheimer Disease - Pathology
(25)
Neurology
(25)
Amyloid Beta-Protein Precursor - Genetics
(23)
Disease Models, Animal
(23)
Alzheimer's Disease
(22)
Biological And Medical Sciences
(20)
Amyloid Beta-Protein Precursor - Metabolism
(19)
Brain - Pathology
(17)
Female
(14)
Male
(14)
Medical Sciences
(14)
Pathology
(14)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Passive immunization reduces behavioral and neuropathological deficits in an alpha-synuclein transgenic model of Lewy body disease

Partial Reduction of BACE1 Has Dramatic Effects on Alzheimer Plaque and Synaptic Pathology in APP Transgenic Mice

Epitope and Isotype Specificities of Antibodies to β-Amyloid Peptide for Protection against Alzheimer's Disease-like Neuropathology

Alterations in synaptic transmission and long-term potentiation in hippocampal slices from young and aged PDAPP mice

Dentate Gyrus Volume Is Reduced before Onset of Plaque Formation in PDAPP Mice: A Magnetic Resonance Microscopy and Stereologic Analysis

Amyloid Deposition in the Hippocampus and Entorhinal Cortex: Quantitative Analysis of a Transgenic Mouse Model

Cholinergic neuropathology in a mouse model of Alzheimer's disease

Selective Vulnerability of Dentate Granule Cells Prior to Amyloid Deposition in PDAPP Mice: Digital Morphometric Analyses

The PDAPP mouse model of Alzheimer's disease: Locus coeruleus neuronal shrinkage

Reducing C-terminal-truncated alpha-synuclein by immunotherapy attenuates neurodegeneration and propagation in Parkinson's disease-like models

Axonopathy in an α -Synuclein Transgenic Model of Lewy Body Disease Is Associated with Extensive Accumulation of C-Terminal–Truncated α -Synuclein

Effects of α-Synuclein Immunization in a Mouse Model of Parkinson’s Disease

Anti-α-synuclein immunotherapy reduces α-synuclein propagation in the axon and degeneration in a combined viral vector and transgenic model of synucleinopathy

Aβ Species Removal After Aβ42 Immunization

Decreased adult hippocampal neurogenesis in the PDAPP mouse model of Alzheimer's disease

S5-03-06: The role of preclinical models in the discovery and development of anti-abeta immunotherapeutics for Alzheimer's disease

Immunotherapy reduces vascular amyloid-beta in PDAPP mice

Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

Neutralization of soluble, synaptotoxic amyloid β species by antibodies is epitope specific

Mice as models: transgenic approaches and Alzheimer's disease

Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse

Apolipoprotein D mRNA expression is elevated in PDAPP transgenic mice

Vascular alterations in PDAPP mice after anti-Aβ immunotherapy: Implications for amyloid-related imaging abnormalities

Beta-amyloid immunotherapy prevents synaptic degeneration in a mouse model of Alzheimer's disease

Non-Fc-Mediated Mechanisms Are Involved in Clearance of Amyloid-beta In Vivo by Immunotherapy

Suchergebnisse filtern